Novel diamino derivatives of [1,2,4]triazolo[1,5-a][1,3,5]triazine as potent and selective adenosine A2a receptor antagonists. 2005

Chi B Vu, and Deborah Pan, and Bo Peng, and Gnanasambandam Kumaravel, and Glenn Smits, and Xiaowei Jin, and Deepali Phadke, and Thomas Engber, and Carol Huang, and Jennifer Reilly, and Stacy Tam, and Donna Grant, and Gregg Hetu, and Russell C Petter
Department of Medicinal Chemistry, Biogen Idec, Inc., 14 Cambridge Center, Cambridge, Massachusetts 02142, USA. chi.vu@biogenidec.com

Piperazine derivatives of 2-furanyl[1,2,4]triazolo[1,5-a][1,3,5]triazine have recently been demonstrated to be potent and selective adenosine A(2a) receptor antagonists with oral activity in rodent models of Parkinson's disease. We have replaced the piperazinyl group with a variety of linear, monocyclic, and bicyclic diamines. Of these diamines, (R)-2-(aminomethyl)pyrrolidine is a particularly potent and selective replacement for the piperazinyl group. With this diamine component, we have been able to prepare numerous analogues with low nanomolar affinity toward the A(2a) receptor and good selectivity with respect to the A(1) receptor (>200-fold in some cases). Selected analogues from this series of [1,2,4]triazolo[1,5-a][1,3,5]triazine have now been shown to be orally active in the mouse catalepsy model.

UI MeSH Term Description Entries
D008297 Male Males
D011759 Pyrrolidines Compounds also known as tetrahydropyridines with general molecular formula (CH2)4NH. Tetrahydropyridine,Tetrahydropyridines
D011869 Radioligand Assay Quantitative determination of receptor (binding) proteins in body fluids or tissue using radioactively labeled binding reagents (e.g., antibodies, intracellular receptors, plasma binders). Protein-Binding Radioassay,Radioreceptor Assay,Assay, Radioligand,Assay, Radioreceptor,Assays, Radioligand,Assays, Radioreceptor,Protein Binding Radioassay,Protein-Binding Radioassays,Radioassay, Protein-Binding,Radioassays, Protein-Binding,Radioligand Assays,Radioreceptor Assays
D002375 Catalepsy A condition characterized by inactivity, decreased responsiveness to stimuli, and a tendency to maintain an immobile posture. The limbs tend to remain in whatever position they are placed (waxy flexibility). Catalepsy may be associated with PSYCHOTIC DISORDERS (e.g., SCHIZOPHRENIA, CATATONIC), nervous system drug toxicity, and other conditions. Cerea Flexibilitas,Flexibility, Waxy,Anochlesia,Anochlesias,Catalepsies,Flexibilitas, Cerea,Flexibilities, Waxy,Waxy Flexibilities,Waxy Flexibility
D002540 Cerebral Cortex The thin layer of GRAY MATTER on the surface of the CEREBRAL HEMISPHERES that develops from the TELENCEPHALON and folds into gyri and sulci. It reaches its highest development in humans and is responsible for intellectual faculties and higher mental functions. Allocortex,Archipallium,Cortex Cerebri,Cortical Plate,Paleocortex,Periallocortex,Allocortices,Archipalliums,Cerebral Cortices,Cortex Cerebrus,Cortex, Cerebral,Cortical Plates,Paleocortices,Periallocortices,Plate, Cortical
D003959 Diamines Organic chemicals which have two amino groups in an aliphatic chain. Diamine
D000284 Administration, Oral The giving of drugs, chemicals, or other substances by mouth. Drug Administration, Oral,Administration, Oral Drug,Oral Administration,Oral Drug Administration,Administrations, Oral,Administrations, Oral Drug,Drug Administrations, Oral,Oral Administrations,Oral Drug Administrations
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000978 Antiparkinson Agents Agents used in the treatment of Parkinson's disease. The most commonly used drugs act on the dopaminergic system in the striatum and basal ganglia or are centrally acting muscarinic antagonists. Antiparkinson Drugs,Antiparkinsonian Agents,Antiparkinsonians,Agents, Antiparkinson,Agents, Antiparkinsonian,Drugs, Antiparkinson
D001667 Binding, Competitive The interaction of two or more substrates or ligands with the same binding site. The displacement of one by the other is used in quantitative and selective affinity measurements. Competitive Binding

Related Publications

Chi B Vu, and Deborah Pan, and Bo Peng, and Gnanasambandam Kumaravel, and Glenn Smits, and Xiaowei Jin, and Deepali Phadke, and Thomas Engber, and Carol Huang, and Jennifer Reilly, and Stacy Tam, and Donna Grant, and Gregg Hetu, and Russell C Petter
August 2004, Journal of medicinal chemistry,
Chi B Vu, and Deborah Pan, and Bo Peng, and Gnanasambandam Kumaravel, and Glenn Smits, and Xiaowei Jin, and Deepali Phadke, and Thomas Engber, and Carol Huang, and Jennifer Reilly, and Stacy Tam, and Donna Grant, and Gregg Hetu, and Russell C Petter
February 2009, Bioorganic & medicinal chemistry letters,
Chi B Vu, and Deborah Pan, and Bo Peng, and Gnanasambandam Kumaravel, and Glenn Smits, and Xiaowei Jin, and Deepali Phadke, and Thomas Engber, and Carol Huang, and Jennifer Reilly, and Stacy Tam, and Donna Grant, and Gregg Hetu, and Russell C Petter
November 2005, Bioorganic & medicinal chemistry letters,
Chi B Vu, and Deborah Pan, and Bo Peng, and Gnanasambandam Kumaravel, and Glenn Smits, and Xiaowei Jin, and Deepali Phadke, and Thomas Engber, and Carol Huang, and Jennifer Reilly, and Stacy Tam, and Donna Grant, and Gregg Hetu, and Russell C Petter
March 2007, Bioorganic & medicinal chemistry letters,
Chi B Vu, and Deborah Pan, and Bo Peng, and Gnanasambandam Kumaravel, and Glenn Smits, and Xiaowei Jin, and Deepali Phadke, and Thomas Engber, and Carol Huang, and Jennifer Reilly, and Stacy Tam, and Donna Grant, and Gregg Hetu, and Russell C Petter
October 2010, Bioorganic & medicinal chemistry letters,
Chi B Vu, and Deborah Pan, and Bo Peng, and Gnanasambandam Kumaravel, and Glenn Smits, and Xiaowei Jin, and Deepali Phadke, and Thomas Engber, and Carol Huang, and Jennifer Reilly, and Stacy Tam, and Donna Grant, and Gregg Hetu, and Russell C Petter
October 2013, Archiv der Pharmazie,
Chi B Vu, and Deborah Pan, and Bo Peng, and Gnanasambandam Kumaravel, and Glenn Smits, and Xiaowei Jin, and Deepali Phadke, and Thomas Engber, and Carol Huang, and Jennifer Reilly, and Stacy Tam, and Donna Grant, and Gregg Hetu, and Russell C Petter
April 1996, Farmaco (Societa chimica italiana : 1989),
Chi B Vu, and Deborah Pan, and Bo Peng, and Gnanasambandam Kumaravel, and Glenn Smits, and Xiaowei Jin, and Deepali Phadke, and Thomas Engber, and Carol Huang, and Jennifer Reilly, and Stacy Tam, and Donna Grant, and Gregg Hetu, and Russell C Petter
November 1999, Journal of medicinal chemistry,
Chi B Vu, and Deborah Pan, and Bo Peng, and Gnanasambandam Kumaravel, and Glenn Smits, and Xiaowei Jin, and Deepali Phadke, and Thomas Engber, and Carol Huang, and Jennifer Reilly, and Stacy Tam, and Donna Grant, and Gregg Hetu, and Russell C Petter
March 1996, Journal of medicinal chemistry,
Chi B Vu, and Deborah Pan, and Bo Peng, and Gnanasambandam Kumaravel, and Glenn Smits, and Xiaowei Jin, and Deepali Phadke, and Thomas Engber, and Carol Huang, and Jennifer Reilly, and Stacy Tam, and Donna Grant, and Gregg Hetu, and Russell C Petter
February 2004, Farmaco (Societa chimica italiana : 1989),
Copied contents to your clipboard!